Skip to main content
Equibles

ERIS · Eris Lifesciences Limited · Financials

Use ERIS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ERIS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,309.45 INR +33.20 (+2.60%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 53.94K Avg daily vol (3M) 26.97K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
31.29B +8.1%
FY2026 Revenue FY2018–FY2026
Net Income
6.2B +76.1%
FY2026 Net Income FY2018–FY2026
Operating Cash Flow
5.38B -49.5%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
INR 33.3B 31.29B 28.94B 20.09B 16.85B 13.47B 12.12B 10.74B 9.82B 8.56B
INR 2.85B 2.8B 3.15B 1.83B 1.17B 647.05M 429.85M 502.58M 363.54M 256.42M
INR 1.88B 1.93B 2.31B 848.01M 261.68M 41.46M 18.02M 21.62M 228.95M 105.5M
INR — — — 4.31B 4.05B 4.42B 3.94B 3.31B 3.17B 3.12B
INR -782.3M -89.7M 1.14B 341.85M 304.83M 364.09M 393.62M 348.43M 262.11M 172.51M
INR 7.08B 6.2B 3.52B 3.92B 3.82B 4.06B 3.55B 2.97B 2.91B 2.94B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 2.82B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.